Skip to main content
Evidence-Based Supplement Research
Evidence-Based Supplement Research

Bifidobacterium lactis MAK16B42L and Increased PMN Cell Phagocytic Capacity

Research synthesisModerate evidenceModerate effect4 studies · 4 beneficial · 0 neutral · 0 harmful

Across 4 studies, all reported beneficial effects of Bifidobacterium lactis on PMN cell phagocytic capacity, with a predominant moderate-to-large effect size. Statistically significant improvements were found in 3 of 4 studies. The evidence comes primarily from healthy elderly adults, though one study also included general healthy adults.

  • Studied populations: healthy elderly adults, healthy adults

Caveats: Doses were not reported in the available studies, preventing dose-response conclusions. One study (2000, n=50) did not report statistical significance for the PMN outcome, adding some uncertainty. All studies appear to use related B. lactis strains (HN019 or DGCC 420), but generalization to the specific strain MAK16B42L is indirect.

Generated May 11, 2026
4 of 4 papers
Back to top